Copyright
©The Author(s) 2016.
World J Gastroenterol. Jan 21, 2016; 22(3): 1088-1100
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1088
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1088
Author | Study setting | Effect on CD | Effect on UC |
Ott et al[89], 2014, Germany | Cohort study | IR of EIM | NA |
CD - 161 | |||
UC - 96 | |||
Outcome - Smoking and EIM | |||
Feagins et al[101], 2014, United States | Case-control study | NA with NSAID, antibiotics, stress, smoking, infection and travel in past 3 mo | |
Active IBD - 166 | |||
IBD in remission - 68 | |||
Outcome - triggers for flare of IBD | |||
Ananthakrishnan et al[97], 2013, United States | Multi-institutional cohort study, CD - 5405, UC - 5429 | IR of surgery with psychiatric comorbidity | NA of surgery with psychiatric comorbidity |
Outcome - psychiatric comorbidity and surgery and hospitalisation in CD and UC | |||
Bernstein et al[93], 2010, Canada | Population-based cohort | IR of flare - High perceived stress | |
IBD - 704 | NA with flare - NSAID, antibiotics, non-enteric infection | ||
Outcome - risk factors for flare | |||
Follow-up - 1 yr | |||
Packer et al[110], 2010 | Systematic review, 7 studies | Physical activity significantly increased quality of life and decreased disease activity | |
Outcome - Physical activity and course of IBD | |||
Bitton et al[95], 2008, Canada | Cohort study, | IR with stress/avoidance coping, higher CRP, fistulising disease behaviour, disease confined to the colon | |
101 patients with CD in remission | |||
Outcome - biopsychosocial factors and relapse | |||
Follow-up - 1 yr | |||
Takeuchi et al[25], 2006, United Kingdom | Case series | IR of flare with non-selective NSAID | |
IBD - 209 | |||
Outcome - risk of flare with NSAID | |||
Sandborn et al[100], 2006, United States | RCT - Celecoxib vs placebo for 2 wk | No significant difference between celecoxib (3%) and placebo group (4%) | |
UC - 222 | |||
Outcome - exacerbation during 2 wk | |||
Persoons et al[96], 2005, Belgium | Cohort study | Major depressive disorder associated with reduced response to infliximab | |
CD - 100 | |||
Outcome - major depressive disorder and response to infliximab | |||
Cosnes et al[103], 1999, France | Cohort study | NA between OCP use and disease flare | |
CD - 331 | |||
Outcome - OCP and flare of CD | |||
Follow-up -12 to 18 mo | |||
Cosnes et al[87], 1999, France | Cohort study | IR of flare - Current smokers | |
CD - 622 | NA with flare - Obesity, dyslipidemia and alcohol consumption | ||
Outcome - risk factors for flare of CD | |||
Follow-up -12 to 18 mo | |||
Boyko et al[117], 1998, United States | UC - 209, compared smokers with non-smokers | DR of hospitalisation | |
Outcome: Smoking and course of UC | NA with colectomy rates |
- Citation: Dutta AK, Chacko A. Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol 2016; 22(3): 1088-1100
- URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1088.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1088